This finding is especially inspiring considering that, compared to the nightly use of CPAP machines, the use of GLP-1RAs may be regarded as more convenient and comfortable [47], particularly for patients who have difficulty tolerating device-based therapies
Hypoglycaemia risk When used as monotherapy, GLP-1 receptor agonists carry minimal hypoglycaemia risk due to their glucose-dependent mechanism
But these drugs can have negative side effects
If its an injection, learn the proper technique
Tirzepatide is efficacious, but uncertainties remain regarding its long-term risks, equitable access, external validity, and cost impact, which can only be resolved through further studies
For people starting on compounded semaglutide, the treatment is typically started at a low dose and gradually increased over time until a suitable maintenance dose is reached